Internal Medicine, Gastroenterology · Port Huron, MI
NPI
1871569095
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
1231 Pine Grove Ave, Suite 2a
Port Huron, MI, 48060
Phone (810) 982-8742
Groups this clinician bills Medicare through
Medicare paid, 2024
$189K
2,005 services
Medicare patients, 2024
1,039
Average age 72
Drug cost, 2024
$971K
4,231 prescriptions
Company payments, 2025
$957
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kavita Tumma was code 99213 (office e&m - established), 302 times for 249 patients. In total Kavita Tumma billed 2,005 services in 40 codes, and Medicare paid $189K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 302 | 249 | $57.01 | $17K |
| 43239 Upper GI Endoscopy | Facility | 256 | 253 | $72.31 | $19K |
| 99214 Office E&M - Established | Office | 248 | 200 | $85.59 | $21K |
| 45385 Colonoscopy - Lesion Removal | Facility | 184 | 183 | $192.16 | $35K |
| 45380 Lower GI Endoscopy - Other | Facility | 158 | 158 | $120.05 | $19K |
| 99232 Hospital E&M - Subsequent | Facility | 134 | 73 | $59.59 | $7,985 |
| 99222 Hospital E&M - Initial | Facility | 110 | 100 | $98.74 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 107 | 97 | $11.65 | $1,247 |
| 99203 Office E&M - New | Office | 97 | 97 | $73.21 | $7,101 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 82 | 82 | $163.36 | $13K |
| 45378 Lower GI Endoscopy - Other | Facility | 63 | 63 | $133.65 | $8,420 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 62 | 62 | $163.39 | $10K |
| 43235 Upper GI Endoscopy | Facility | 22 | 21 | $75.97 | $1,671 |
| 43249 Upper GI Endoscopy | Facility | 19 | 19 | $101.33 | $1,925 |
| 99204 Office E&M - New | Office | 19 | 19 | $115.40 | $2,193 |
By year: 2022 $248K for 2,602 services; 2023 $219K for 2,259 services; 2024 $189K for 2,005 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kavita Tumma prescribed most often to Medicare patients was Gavilyte-C (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 1,031 prescriptions and refills. In total Kavita Tumma wrote 4,231 Medicare prescriptions that cost $971K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 1,031 | 1,031 | 1,017 | $19K |
| Omeprazole Generic | 586 | 1,085 | 189 | $6,516 |
| Pantoprazole Sodium Generic | 435 | 779 | 135 | $6,337 |
| Dicyclomine Hcl Generic | 363 | 556 | 129 | $7,926 |
| Famotidine Generic | 256 | 435 | 68 | $1,995 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 110 | 110 | 109 | $2,225 |
| Azathioprine Generic | 100 | 156 | 16 | $5,648 |
| Amitriptyline Hcl Generic | 89 | 147 | 27 | $764 |
| Mesalamine Generic | 85 | 180 | 27 | $59K |
| Sucralfate Generic | 76 | 98 | 22 | $3,901 |
| Balsalazide Disodium Generic | 72 | 115 | 18 | $13K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 62 | 64 | 23 | $2,776 |
| Alprazolam Generic | 45 | 45 | Under 11 | $122 |
| Ondansetron Odt Ondansetron | 41 | 41 | 20 | $1,209 |
| Linzess Linaclotide | 39 | 56 | 12 | $30K |
Brand drugs: - claims; generic drugs: 3,961 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kavita Tumma $957 ($957 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $614.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.